Patent-family-84547304
Applicants:
- SYNACT PHARMA APS
Abstract
The present disclosure relates to a crystalline form of 2-{3-[1-(2-nitrophenyl)-1H-pyrrol- 2-yl]prop-2-en-1-ylidine}hydrazine-1-carboximidamide having high solubility at acidic conditions. The disclosure also relates to use of said crystalline form in medicine.
Patent Family Records (1)
POLYMORPH OF PHENYL PYRROLE HYDRAZINE CARBOXIMIDAMIDE COMPOUND
SYNACT PHARMA APS BOESEN THOMAS, JONASSEN THOMAS ENGELBRECHT NORDKILD, Reece Hayley Ann, (...more)
2024, WO-2024133643-A1